Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad A Racette

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Neurotoxicology|October 24, 2013
Manganism in the 21st century: the Hanninen lectureBrad A Racette
Neurology|June 14, 2015
Time to change the blind men and the elephant approach to Parkinson disease?Brad A Racette, Allison W Willis
Pediatric Neurology|September 23, 2008
Prospective study examining remote effects of botulinum toxin a in children with cerebral palsyBeth E Crowner, Brad A Racette
Current Epidemiology Reports|June 6, 2015
Neuromythology of ManganismKristin M Andruska, And Brad A Racette
Parkinsonism & Related Disorders|October 13, 2009
Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysisAllison W Willis, Callen Sterling, Brad A Racette
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024)Brad A Racette, Mikula Stambuk, Joel S Perlmutter
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2003
Dystonia in a patient with ring chromosome 21Craig E Hou, Bradley L Schlaggar, Brad A Racette
The Annals of Occupational Hygiene|September 28, 2010
Estimation of particulate mass and manganese exposure levels among weldersAngela Hobson, Noah Seixas, David Sterling, et al.
Parkinson'S Disease|March 10, 2020
Validation of a Parkinson Disease Predictive Model in a Population-Based StudyIrene M Faust, Brad A Racette, Susan Searles Nielsen
Clinical Neuropharmacology|October 3, 2007
Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patientBeth E Crowner, Janice E Brunstrom, Brad A Racette
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Neurotoxicology|October 24, 2013
Manganism in the 21st century: the Hanninen lectureBrad A Racette
Neurology|June 14, 2015
Time to change the blind men and the elephant approach to Parkinson disease?Brad A Racette, Allison W Willis
Pediatric Neurology|September 23, 2008
Prospective study examining remote effects of botulinum toxin a in children with cerebral palsyBeth E Crowner, Brad A Racette
Current Epidemiology Reports|June 6, 2015
Neuromythology of ManganismKristin M Andruska, And Brad A Racette
Parkinsonism & Related Disorders|October 13, 2009
Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysisAllison W Willis, Callen Sterling, Brad A Racette
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024)Brad A Racette, Mikula Stambuk, Joel S Perlmutter
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2003
Dystonia in a patient with ring chromosome 21Craig E Hou, Bradley L Schlaggar, Brad A Racette
The Annals of Occupational Hygiene|September 28, 2010
Estimation of particulate mass and manganese exposure levels among weldersAngela Hobson, Noah Seixas, David Sterling, et al.
Parkinson'S Disease|March 10, 2020
Validation of a Parkinson Disease Predictive Model in a Population-Based StudyIrene M Faust, Brad A Racette, Susan Searles Nielsen
Clinical Neuropharmacology|October 3, 2007
Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patientBeth E Crowner, Janice E Brunstrom, Brad A Racette
Pageof 12